Compare ARVN & OBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARVN | OBT |
|---|---|---|
| Founded | 2015 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 516.2M | 457.5M |
| IPO Year | 2018 | 2021 |
| Metric | ARVN | OBT |
|---|---|---|
| Price | $9.20 | $38.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 1 |
| Target Price | $15.05 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 878.8K | 52.7K |
| Earning Date | 05-04-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.12% |
| EPS Growth | ★ 58.84 | 34.82 |
| EPS | 1.70 | ★ 1.87 |
| Revenue | ★ $262,600,000.00 | N/A |
| Revenue This Year | N/A | $14.27 |
| Revenue Next Year | N/A | $7.99 |
| P/E Ratio | ★ $5.28 | $20.96 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.96 | $23.25 |
| 52 Week High | $14.22 | $40.10 |
| Indicator | ARVN | OBT |
|---|---|---|
| Relative Strength Index (RSI) | 64.01 | 61.59 |
| Support Level | $7.90 | $35.90 |
| Resistance Level | $9.65 | $40.10 |
| Average True Range (ATR) | 0.40 | 0.88 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 75.50 | 66.60 |
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
Orange County Bancorp Inc is a community bank holding company providing commercial and consumer banking services to individuals, small businesses, and local governments. It operates through two segments: Banking and Wealth Management. The Banking segment, the primary revenue driver, offers loans such as commercial real estate, construction, commercial & industrial, multifamily, and residential mortgages, along with services like cash management, escrow, deposits, ATMs, and digital banking. The Wealth Management segment provides investment management, trust services (trustee, administrator, custodian), and financial planning and advisory services to individuals and institutions.